Search results for "Familial"

showing 10 items of 365 documents

Familial Mediterranean fever as an unusual cause of acute scrotum.

2001

Correct preoperative diagnosis is the crucial step in the management of acute scrotum. With the adjunct of color Doppler ultrasound, torsion of testicular appendages, epidydimitis and orchitis as the more common nonsurgical causes are differentiated reliably from testicular torsion or incarcerated inguinal hernia. Less frequently, acute scrotal swelling is the initial symptom of systemic disorders. Leukemic infiltration of the testis or scrotal involvement in vasculitis

Maleendocrine systemmedicine.medical_specialtyendocrine system diseasesUrologyFamilial Mediterranean feverAcute scrotumurologic and male genital diseasesScrotumMedicineTesticular torsionHumansLeukemic Infiltrationurogenital systembusiness.industryInfantmedicine.diseaseSurgeryFamilial Mediterranean Feversurgical procedures operativemedicine.anatomical_structureScrotumOrchitisIncarcerated Inguinal HerniaGenital Diseases MalebusinessVasculitisThe Journal of urology
researchProduct

Familial Mediterranean Fever: an unusual cause of liver disease

2019

Abstract Background Familial Mediterranean Fever is an autoinflammatory disease typically expressed with recurrent attacks of fever, serositis, aphthous stomatitis, rash. Only a few reports describe the association with hepatic involvement. Case presentation We describe the clinical case of a child affected, since the age of 1 year, by recurrent fever, aphthous stomatitis, rash, arthralgia, associated with abdominal pain, vomiting, lymphadenopathy. The diagnosis of Familial Mediterranean Fever was confirmed by the genetic study of MEFV gene; the homozygous mutation M694 V in exon was documented. A partial control of attacks was obtained with colchicine. The child continued to manifest only …

Malemedicine.medical_specialtyAbdominal painCanakinumabFamilial Mediterranean feverCase ReportFamilial Mediterranean feverGastroenterology03 medical and health scienceschemistry.chemical_compoundLiver disease0302 clinical medicineSettore MED/38 - Pediatria Generale E Specialistica030225 pediatricsInternal medicineHumansMedicineColchicine030212 general & internal medicineSerum amyloid AChildbusiness.industryLiver Diseaseslcsh:RJ1-570lcsh:Pediatricsmedicine.diseaseMEFVRashchemistrymedicine.symptombusinessColchicineSerositisLiver diseaseItalian Journal of Pediatrics
researchProduct

Event-related potentials in newborns with and without familial risk for dyslexia: principal component analysis reveals differences between the groups

2003

Differences revealed by factor scores extracted by principal component analysis (PCA) from event-related potential (ERP) data of newborns with and without familial risk for dyslexia were examined and compared to results obtained by using original averaged ERPs. ERPs to consonant-vowel syllables (synthetic /ba/, /da/, /ga/; and natural /paa/, /taa/, /kaa/) were recorded from 26 at-risk and 23 control 1-7 day-old infants. The stimuli were presented equiprobably and with interstimulus intervals varying at random from 3,910 to 7,285 ms. Statistically significant between-group differences were found to be relatively similar irrespective of the methods of analysis (original ERPs vs. factor scores…

Malemedicine.medical_specialtyAudiologyStimulus (physiology)behavioral disciplines and activitiesFunctional LateralityDevelopmental psychologyDyslexiaText miningPredictive Value of TestsEvent-related potentialCommunication disorderReaction TimemedicineHumansGenetic Predisposition to DiseaseLanguage disorderEvoked PotentialsBiological PsychiatryFamily HealthAnalysis of VariancePrincipal Component AnalysisLanguage TestsVerbal Behaviorbusiness.industryInfant NewbornDyslexiaBrainGenetic VariationReproducibility of ResultsElectroencephalographyFamilial riskmedicine.diseasePsychiatry and Mental healthAcoustic StimulationNeurologyPrincipal component analysisEvoked Potentials AuditoryFemaleNeurology (clinical)PsychologybusinessJournal of Neural Transmission
researchProduct

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

2003

Headache attacks and autonomic dysfunctions characterize migraine, a very common, disabling disorder with a prevalence of 12% in the general population of Western countries(1,2). About 20% of individuals affected with migraine experience aura, a visual or sensory-motor neurological dysfunction that usually precedes or accompanies the headache(3). Although the mode of transmission is controversial(4), population-based and twin studies have implicated genetic factors, especially in migraine with aura(5,6). Familial hemiplegic migraine is a hereditary form of migraine characterized by aura and some hemiparesis. Here we show that mutations in the gene ATP1A2 that encodes the alpha2 subunit of t…

Malemedicine.medical_specialtyAuraCell SurvivalPopulationMigraine with AuraMolecular Sequence DataDrug ResistanceBiologyHaploidyTransfectionATP1A2Internal medicineATP1A3Chlorocebus aethiopsGeneticsmedicineAnimalsHumansEnzyme InhibitorseducationOuabainFamilial hemiplegic migraineChromatography High Pressure LiquidGeneticseducation.field_of_studyBase Sequencemedicine.diseaseMigraine with auraPeptide FragmentsPedigreeEndocrinologyMigraineChromosomes Human Pair 1Case-Control StudiesCOS CellsMutationMutagenesis Site-DirectedFemaleCalcium Channelsmedicine.symptomSodium-Potassium-Exchanging ATPaseHaploinsufficiencyHeLa CellsNature genetics
researchProduct

Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey

2018

Aims: Familial hypercholesterolaemia (FH) accelerates atherosclerotic cardiovascular disease (ASCVD) and accordingly is the most potent hereditary cause of premature coronary heart disease. The association between telomere length (TL), a biological index of ageing, and FH has not been hitherto investigated. We addressed this question using data from the US National Health and Education National Surveys (NHANES, 1999-2002).Methods and results: We included individuals, who had TL measurements (with quantitative polymerase chain reaction method) and a phenotypic diagnosis of FH based on the Dutch Lipid Clinic Network (DLCN) criteria. Sample weights were applied for unequal probabilities of sel…

Malemedicine.medical_specialtyNational Health and Nutrition Examination SurveyCross-sectional studyPopulationFamilial hypercholesterolemia030204 cardiovascular system & hematologyHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumans030212 general & internal medicineeducationNational Health and Education National Surveyseducation.field_of_studyTelomere lengthbusiness.industryMiddle AgedTelomeremedicine.diseaseNutrition SurveysObesityConfidence intervalUnited StatesCross-Sectional StudiesQuartileFemaleCardiology and Cardiovascular MedicinebusinessFamilial hypercholesterolaemiaBody mass indexEuropean Heart Journal
researchProduct

Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy

2016

Transthyretin familial amyloid polyneuropathy (TTR-FAP) is an inherited amyloidosis, leading to death in about ten years in most cases due to cardiac failure or wasting syndrome. Previous studies showed that modified body mass index was related to time before death, duration of gastrointestinal disturbances, malabsorption and functional capacity. We report two patients in whom nutritional status worsened despite diet modification, hypercaloric supplement and two relevant therapeutic approaches such as liver transplant and tafamidis meglumine, respectively. The first patient, a 52-year-old lady carrying Thr49Ala mutation, had a disease duration of twelve years and had lost weight up to 35 kg…

Malemedicine.medical_specialtyPediatricsMalabsorptionNausea030204 cardiovascular system & hematologyPediatrics03 medical and health sciences0302 clinical medicineQuality of lifeNutritional statusMedicineHumansWasting SyndromeTTR-FAPGenetics (clinical)Amyloid Neuropathies FamilialFamilial amyloid polyneuropathy; Modified body mass index (mBMI); Nutritional status; Parenteral nutrition; TTR-FAP; Neurology (clinical); Pediatrics Perinatology and Child Health; Genetics (clinical); Neurologybiologybusiness.industryAmyloidosisMiddle AgedPerinatology and Child Healthmedicine.diseaseParenteral nutritionSurgeryTransthyretinParenteral nutritionTreatment OutcomeAutonomic Nervous System DiseasesNeurologyFamilial amyloid polyneuropathyPediatrics Perinatology and Child Healthbiology.proteinQuality of LifeFemaleNeurology (clinical)medicine.symptombusinessBody mass index030217 neurology & neurosurgeryModified body mass index (mBMI)
researchProduct

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm,…

2013

Summary Background Patients with homozygous familial hypercholesterolaemia respond inadequately to existing drugs. We aimed to assess the efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in adults with this disease. Methods We did a single-arm, open-label, phase 3 study of lomitapide for treatment of patients with homozygous familial hypercholesterolemia. Current lipid lowering therapy was maintained from 6 weeks before baseline through to at least week 26. Lomitapide dose was escalated on the basis of safety and tolerability from 5 mg to a maximum of 60 mg a day. The primary endpoint was mean percent change in levels of LDL cholesterol from baseline …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaMipomersenPhases of clinical researchSocio-culturaleFamilial hypercholesterolemialdl-apheresismtp inhibitorBenzimidazoleMicrosomal triglyceride transfer proteinHyperlipoproteinemia Type IIchemistry.chemical_compoundlipid lowering therapyInternal medicineClinical endpointMedicinelomitapidebiologybusiness.industryCholesterolMedicine (all)Homozygotelomitapide; ldl-apheresis; lipid lowering therapy; homozygous familial hypercholesterolemia; mtp inhibitorGeneral MedicineCholesterol LDLhomozygous familial hypercholesterolemiamedicine.diseaseLomitapideEndocrinologyTolerabilitychemistrybiology.proteinFemalebusinessCarrier ProteinHuman
researchProduct

Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and no…

2020

Patients with familial hypercholesterolemia (FH) are prone to develop acute myocardial infarction (AMI) at a younger age.The aim of the present study was to assess 5-year outcomes after AMI according to the presence of FH in a large multicenter cohort of patients.The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction consists of nationwide surveys recruiting patients over a 1- to 2-month period every 5 years. Patients recruited in 2005 and 2010 were followed up to 5 years.Of 5147 patients discharged alive and in whom FH status could be assessed, 2.8% had probable/definite FH, using an adapted Dutch Lipid Clinic score. They were 12 years younger, on average, tha…

Malemedicine.medical_specialty[SDV]Life Sciences [q-bio]Endocrinology Diabetes and MetabolismFamilial hypercholesterolemia030204 cardiovascular system & hematologyCohort StudiesHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineSurveys and QuestionnairesInternal MedicinemedicineHumansIn patient030212 general & internal medicineMyocardial infarctionRegistriesNon-ST Elevated Myocardial InfarctionStrokeComputingMilieux_MISCELLANEOUSAgedNutrition and Dieteticsbusiness.industryST elevationHazard ratioMiddle Agedmedicine.diseasePrognosisConfidence interval3. Good healthCohortST Elevation Myocardial Infarction[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessJournal of clinical lipidology
researchProduct

High frequency of colorectal adenoma in patients with duodenal adenoma but without familial adenomatous polyposis

2004

Abstract Background Duodenal adenomas are extremely common in patients with familial adenomatous polyposis. However, it is uncertain whether patients with duodenal adenomas without familial adenomatous polyposis are at greater risk for colorectal neoplasia and, therefore, should routinely undergo surveillance colonoscopy. The aim of this study was to determine whether there is a correlation between non-papillary duodenal adenoma without familial adenomatous polyposis and colorectal adenoma. Methods Twenty-five patients with non-papillary duodenal adenomas without familial adenomatous polyposis, seen from January 1990 to April 2003, were retrospectively evaluated. Results Non-papillary duode…

Malemedicine.medical_specialtyendocrine system diseasesColorectal cancerBiopsyPopulationColonic PolypsColonoscopyColorectal adenomaGastroenterologyFamilial adenomatous polyposisNeoplasms Multiple PrimaryDuodenal AdenomaDuodenal NeoplasmsInternal medicineAdenoma VillousmedicineHumansRadiology Nuclear Medicine and imagingIntestinal MucosaeducationAgededucation.field_of_studymedicine.diagnostic_testbusiness.industryGastroenterologyPapillary AdenomaMiddle Agedmedicine.diseasedigestive system diseasesProctoscopystomatognathic diseasesCross-Sectional StudiesAdenomatous Polyposis ColiPopulation SurveillanceFemaleColorectal NeoplasmsbusinessGastrointestinal Endoscopy
researchProduct

FABP4 plasma levels are increased in familial combined hyperlipidemia

2010

The lipid profile of familial combined hyperlipidemia (FCHL) shares some characteristics with atherogenic dyslipidemia seen in diabetes, metabolic syndrome, and obesity. Adipocyte fatty acid-binding protein 4 (FABP4) appears to be a determinant of atherogenic dyslipidemia. We examined relationships between FABP4 plasma concentrations, dyslipidemia, and metabolic variables in patients with FCHL. We studied 273 unrelated FCHL patients and 118 control subjects. FABP4 was higher in FCHL than controls, with mean levels of 21.8 (10.1) microg/l and 19.2 (9.2) microg/l, respectively (adjusted P= 0.012). In FCHL, FABP4 correlated to body mass index (BMI), waist circumference, insulin levels, and hom…

Maleobesitymedicine.medical_specialtyMagnetic Resonance Spectroscopymedicine.medical_treatmentHyperlipidemia Familial CombinedQD415-436Fatty Acid-Binding ProteinsBiochemistryCohort StudiesInsulin resistanceEndocrinologyinsulin resistanceInternal medicineDiabetes mellitusmedicineHumansmedicine.diagnostic_testbusiness.industryInsulindyslipidemiaHypertriglyceridemiaCell BiologyMiddle AgedLipid Metabolismmedicine.diseaseEndocrinologyFCHLFemaleMetabolic syndromePatient-Oriented and Epidemiological ResearchLipid profilebusinessBody mass indexDyslipidemiaJournal of Lipid Research
researchProduct